Author： Dominguez Celia Tamayo Nuria Zhang Dawei
Publisher： Informa Healthcare
ISSN： 1354-3776
Source： Expert Opinion on Therapeutic Patents, Vol.15, Iss.7, 2005-07, pp. : 801-816
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Hanson G.J.
Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 7, 1997-07 ,pp. :
Access to resources
Recommend
Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 1, 2000-01 ,pp. :
Allosteric p38 kinase inhibitors
By Norman Peter
Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 10, 2006-10 ,pp. :
By Norman Peter
Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 7, 2008-07 ,pp. :
p38 Inhibitors based on the pyridylurea and pyridylacetoamide templates
Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 7, 2000-07 ,pp. :